 "Sun Pharma extends savings card program for cancer drug in US")
Marksans Pharma has moved higher by 12% to Rs 53.55 on the BSE after the company announced that it has got US drug regulator nod for loratadine liquid filed capsules 10 mg.
“The US Food & Drug Administration (USFDA) has granted approval for an Abbreviated New Drug Application (ANDA) for Loratadine liquid filed capsules 10 mg,” Marksans Pharma said in a press release.
Loratadine liquid filed capsules 10 mg is therapeutically equivalent to the reference listed drug Claritin Liqui-Gels Capsules 10 mg of Bayer Healthcare LLC.
Loratadine is an antihistamine that reduces the effects of natural chemical histamine in the body. Loratadine is used to treat sneezing, runny nose, watery eyes, hives, skin rash, itching, and other cold or allergy symptoms.
Thus far in September, the stock outperformed the market by surging 31% from Rs 40.75, as compared to 0.22% rise in the S&P BSE Sensex.
At 11:03 am, the stock was up 11% at Rs 53.10, against 0.53% decline in the benchmark index. The counter has seen huge trading volumes with a combined 12.43 million shares changing hands on the BSE and NSE so far.
“The US Food & Drug Administration (USFDA) has granted approval for an Abbreviated New Drug Application (ANDA) for Loratadine liquid filed capsules 10 mg,” Marksans Pharma said in a press release.
Loratadine liquid filed capsules 10 mg is therapeutically equivalent to the reference listed drug Claritin Liqui-Gels Capsules 10 mg of Bayer Healthcare LLC.
Loratadine is an antihistamine that reduces the effects of natural chemical histamine in the body. Loratadine is used to treat sneezing, runny nose, watery eyes, hives, skin rash, itching, and other cold or allergy symptoms.
Thus far in September, the stock outperformed the market by surging 31% from Rs 40.75, as compared to 0.22% rise in the S&P BSE Sensex.
At 11:03 am, the stock was up 11% at Rs 53.10, against 0.53% decline in the benchmark index. The counter has seen huge trading volumes with a combined 12.43 million shares changing hands on the BSE and NSE so far.
